<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335033">
  <stage>Registered</stage>
  <submitdate>16/01/2010</submitdate>
  <approvaldate>12/03/2010</approvaldate>
  <actrnumber>ACTRN12610000208000</actrnumber>
  <trial_identification>
    <studytitle>T2-T6 Ultrasound guided Intercostal blocks versus General anaesthesia in quadrantectomies for perioperative and chronic pain management</studytitle>
    <scientifictitle>T2-T6 Ultrasound guided Intercostal blocks versus General anaesthesia in quadrantectomies for perioperative and chronic pain management in women with breast cancer.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>We study the possibility that regional anaesthesia in breast surgery can reduce neuropathic long term pain, as a preemptive analgesia. Patients undergoing quadrantectomies without axillary dissection.</healthcondition>
    <healthcondition>We study the possibility that regional anaesthesia in breast surgery can reduce postoperative pain, with a reduction of use of tramadol. Patients undergoing quadrantectomies without axillary dissection.</healthcondition>
    <healthcondition>We study the possibility that regional anaesthesia can reduce hospitalization, operatory room occupation and costs.  Patients undergoing quadrantectomies without axillary dissection.</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Breast</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Regional anaesthesia. T2-T6 ultrasound guided intercostal blocks for quadrantectomies. The techique lasts a few minutes (max 3) and consists in infiltrating under ultrasound guidance the intercostal nerves from T2 to T6 with 3ml of ropivacaine 7.5mg/ml for each space. The technique is performed just once, before the intervention and non other treatment is required.</interventions>
    <comparator>General anaesthesia. Duration: 30 minutes approximately, depending on the duration of the surgery. We perform a standard total intraveous general anaesthesia (TIVA) with propofol and remifentanyl continuous infusion. We position a laryngeal mask after induction with propofol 2mg/kg, Fentanyl 0.1mg and cisatracurium 0.1mg/kg.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>VAS (visual analogic score) pain score 24 hours and then 2 years after intervention.</outcome>
      <timepoint>24 hours and then 2 years after the last quadrantectomy.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Hospitalization and operatory room occupation. The hospitalization depends on clinical conditions and complications occurred, reported in medical records.</outcome>
      <timepoint>End 2 years after the beginning of the study.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Evaluation of the therapy and its impact on the patient's life. Evaluation based on questionnaires.</outcome>
      <timepoint>End 2 years aftyer the last quadrantectomy.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Evaluation of anthalgic therapy (tramadol) in the 24h following the intervention. Evaluation based on medical records.</outcome>
      <timepoint>End 2 years after the beginning of the study.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Evaluation of costs for the hospital and overall management: operatory room occupation, hours of hospitalization. Evaluation based on medical records.</outcome>
      <timepoint>End 2 years after the beginning of the study.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Classification American Society of Anaesthesiologists (ASA) 1-2-3.
Patients with breaast cancer scheduled for quadrantectomy without axillary dissection.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Classification American Society of Anaesthesiologists (ASA) 4.
Coagulation pathology.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/09/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Italy</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mazza Andrea</primarysponsorname>
    <primarysponsoraddress>via XXV Aprile 128
17027 Pietra Ligure SV</primarysponsoraddress>
    <primarysponsorcountry>Italy</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>ASL2 Savonese PO S.Corona</fundingname>
      <fundingaddress>via XXV Aprile 128
17027 Pietra Ligure SV</fundingaddress>
      <fundingcountry>Italy</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>ASL2 Savonese PO S.Corona</sponsorname>
      <sponsoraddress>via XXV Aprile 128
17027 Pietra Ligure SV</sponsoraddress>
      <sponsorcountry>Italy</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Centro Trials IST</othercollaboratorname>
      <othercollaboratoraddress>IST Istituto Tumori Genova
Centro Trials
Largo Rosanna Benzi, 10 - 16132 GENOVA - ITALY</othercollaboratoraddress>
      <othercollaboratorcountry>Italy</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is designed to decide if a regional anaesthesia for quadrantectomies is better than a general anaesthesia (the standard treatment). Pain and organization are the main outcomes. This new technique offers the possibility to reduce complications in patients with cardiovascular and lung comorbidities.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrea Mazza</name>
      <address>Ospedale Santa Corona
via XXV Aprile 128
17027 Pietra Ligure SV</address>
      <phone>00393405954159</phone>
      <fax />
      <email>andrea.mazza@email.it</email>
      <country>Italy</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Andrea Mazza</name>
      <address>Ospedale Santa Corona
via XXV Aprile 128
17027 Pietra Ligure SV</address>
      <phone>00393405954159</phone>
      <fax />
      <email>andrea.mazza@email.it</email>
      <country>Italy</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>